Heart Transplant Failure and Rejection Clinical Trial
Official title:
A Phase 1 Study of Daratumumab for Reduction of Circulating Antibodies in Patients With High Allosensitization Awaiting Heart Transplantation
The purpose of this study is to test whether daratumumab, a drug that eliminates antibody-producing plasma cells, can effectively lower the level of preformed antibodies in patients awaiting heart transplantation. These preformed antibodies limit the number of donor hearts that are compatible for the patients. If daratumumab can effectively remove preformed, donor-specific antibodies, then highly allosensitized patients will have more compatible hearts available to them, potentially decreasing transplant waitlist time and reducing mortality.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03102125 -
Allograft Dysfunction in Heart Transplant
|
Phase 4 | |
| Active, not recruiting |
NCT04380311 -
Precision Guided Tacrolimus Dosing in Pediatric Heart Transplant
|
N/A | |
| Completed |
NCT02109575 -
Quantitative Detection of Circulating Donor-Specific DNA in Organ Transplant Recipients (DTRT-Multi-Center Study)
|
||
| Not yet recruiting |
NCT06414603 -
A Comparative Effectiveness Study in Heart Transplant Patients of Rejection Surveillance With Cell-free DNA Versus Endomyocardial Biopsy
|
N/A | |
| Completed |
NCT04610320 -
Daratumumab-SC for Highly Sensitized Patients Awaiting Heart Transplantation
|
Phase 1 | |
| Active, not recruiting |
NCT03386539 -
Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score
|
Phase 3 | |
| Withdrawn |
NCT05081739 -
Donor-Derived Cell-free DNA to DETect REjection in Cardiac Transplantation
|
N/A | |
| Recruiting |
NCT03499197 -
Heart TIMING - Heart Transplantation IMagING
|
||
| Recruiting |
NCT03538509 -
Percutaneous Coronary Intervention in Patients witH OrthotoPic hEart Transplantation: the PCI-HOPE a Multicenter Study.
|
||
| Recruiting |
NCT03050892 -
Impact of Donor and Recipient ST2 / IL-33 Pathway After Heart Transplantation
|
N/A | |
| Active, not recruiting |
NCT03373279 -
Bioelectrical Impedance Spectroscopy in Heart Transplantation: Tracking Post-Transplant Changes in Body Composition and Correlation With Conventional Preoperative Risk Assessment Modalities
|
||
| Recruiting |
NCT05994274 -
A Clinical Study of Association Between Postoperative Dyslipidemia and Organ Rejection in Transplant Patients
|
||
| Active, not recruiting |
NCT03575910 -
HEARTBiT: Multi-Marker Blood Test for Acute Cardiac Transplant Rejection
|
||
| Not yet recruiting |
NCT06453148 -
Brazilian Clinical Registry of Heart Transplantation
|